Source: Nutrición Hospitalaria. Unidade: FMRP
Subjects: INTESTINO DELGADO, HEPATOPATIAS, FÁRMACOS GASTRINTESTINAIS (TRATAMENTO), RESSONÂNCIA MAGNÉTICA
ABNT
ARAÚJO, Guilherme Teixeira et al. Betaine: a potential agent for the treatment of hepatopathy associated with short bowel syndrome. Nutrición Hospitalaria, v. 29, n. 6, p. 1366-1371, 2014Tradução . . Disponível em: https://doi.org/10.3305/nh.2014.29.6.7378. Acesso em: 07 nov. 2024.APA
Araújo, G. T., Domenici, F., Elias Júnior, J., & Vannucchi, H. (2014). Betaine: a potential agent for the treatment of hepatopathy associated with short bowel syndrome. Nutrición Hospitalaria, 29( 6), 1366-1371. doi:10.3305/nh.2014.29.6.7378NLM
Araújo GT, Domenici F, Elias Júnior J, Vannucchi H. Betaine: a potential agent for the treatment of hepatopathy associated with short bowel syndrome [Internet]. Nutrición Hospitalaria. 2014 ; 29( 6): 1366-1371.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3305/nh.2014.29.6.7378Vancouver
Araújo GT, Domenici F, Elias Júnior J, Vannucchi H. Betaine: a potential agent for the treatment of hepatopathy associated with short bowel syndrome [Internet]. Nutrición Hospitalaria. 2014 ; 29( 6): 1366-1371.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3305/nh.2014.29.6.7378